Organized by nine laboratories on five continents, the study by some members of the Global Diagnostics Network, a Quest Diagnostics (DGX)-led strategic working group, is the largest to evaluate ...
ZyVersa is developing Cholesterol Efflux Mediator™ VAR 200 to mediate removal of damaging excess cholesterol and other lipids from the kidneys’ filtration system. VAR 200 directly removes lipids from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results